Answers are grounded in this paper and cite their sources.
Introduction: Lung cancer is a common disease, with a poor prognosis. micrornas are small non-coding RNA particles, involved in regulating gene expression. during the past decade, microrna profiling studies have been performed pointing at micrornas as compelling biomarkers for diagnostics, prognostics and for prediction of therapy response.Areas covered: MicroRNA profiles have been identified differentiating between normal lung biopsies and lung adenocarcinomas, and also correlated with different clinical characteristics. Herein, I discuss some of the findings in studies of microRNA profiling in lung adenocarcinomas, and the possibilities we have for future use of these.Expert commentary: MicroRNA profiles bear great potential as robust biomarkers in lung adenocarcinomas. In addition, profiling studies provide insight about lung cancer carcinogenesis and biology. Unfortunately, there is little overlap between microRNA profiles identified in the different studies, and in future studies validation in external patient material would be important.
No takes yet. Share an insight, caveat, or question.
Åslaug Helland (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: